Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 978 entries
Sorted by: Best Match Show Resources per page
Design specification in Japan: Tree-structured charts

program design

Aoyama M.
GSID: QytOJUY578UJ
M Aoyama, K Miyamoto, N Murakami, H Nagano… - IEEE …, 1989 - ieeexplore.ieee.org

The authors describe a novel design specification method, the tree-structured chart, that has been accepted widely in Japan because it improves productivity and quality. Tree-structured …

Cite
Aoyama, M., Miyamoto, K., Murakami, N., Nagano, H., & Oki, Y. (1989). Design specification in Japan: Tree-structured charts. IEEE Software, 6(2), 31-37.
Aoyama, Mikio, et al. "Design specification in Japan: Tree-structured charts." IEEE Software 6.2 (1989): 31-37.
Copy Download .nbib Format: MLA
[Clinical essay. Knowledge and wisdom].

Kurinikaru sutadi = Clinical study

Akiyama F.
PMID: 6911396
Kurinikaru Sutadi. 1981 May;2(5):633-5.

No abstract available.

Cite
Akiyama F. [Clinical essay. Knowledge and wisdom]. Kurinikaru Sutadi. 1981;2(5):633-5
Akiyama, F. (1981). [Clinical essay. Knowledge and wisdom]. Kurinikaru sutadi = Clinical study, 2(5), 633-5.
Akiyama, F. "[Clinical essay. Knowledge and wisdom]." Kurinikaru sutadi = Clinical study vol. 2,5 (1981): 633-5.
Akiyama F. [Clinical essay. Knowledge and wisdom]. Kurinikaru Sutadi. 1981 May;2(5):633-5. Japanese. PMID: 6911396.
Copy Download .nbib Format: NLM
[Management of mild hypertension].

Nihon Ishikai zasshi. Journal of the Japan Medical Association

Akiyama F.
PMID: 5951348
Nihon Ishikai Zasshi. 1966 Mar 15;55(6):847-59.

No abstract available.

Cite
Akiyama F. [Management of mild hypertension]. Nihon Ishikai Zasshi. 1966;55(6):847-59
Akiyama, F. (1966). [Management of mild hypertension]. Nihon Ishikai zasshi. Journal of the Japan Medical Association, 55(6), 847-59.
Akiyama, F. "[Management of mild hypertension]." Nihon Ishikai zasshi. Journal of the Japan Medical Association vol. 55,6 (1966): 847-59.
Akiyama F. [Management of mild hypertension]. Nihon Ishikai Zasshi. 1966 Mar 15;55(6):847-59. Japanese. PMID: 5951348.
Copy Download .nbib Format: NLM
An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation.

PloS one

Nguyen HT, Md Dawal SZ, Nukman Y, Aoyama H, Case K.
PMID: 26368541
PLoS One. 2015 Sep 14;10(9):e0133599. doi: 10.1371/journal.pone.0133599. eCollection 2015.

Globalization of business and competitiveness in manufacturing has forced companies to improve their manufacturing facilities to respond to market requirements. Machine tool evaluation involves an essential decision using imprecise and vague information, and plays a major role to improve...

Cite
Nguyen HT, Md Dawal SZ, Nukman Y, et al. An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation. PLoS One. 2015;10(9):e0133599doi: 10.1371/journal.pone.0133599.
Nguyen, H. T., Md Dawal, S. Z., Nukman, Y., Aoyama, H., & Case, K. (2015). An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation. PloS one, 10(9), e0133599. https://doi.org/10.1371/journal.pone.0133599
Nguyen, Huu-Tho, et al. "An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation." PloS one vol. 10,9 (2015): e0133599. doi: https://doi.org/10.1371/journal.pone.0133599
Nguyen HT, Md Dawal SZ, Nukman Y, Aoyama H, Case K. An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation. PLoS One. 2015 Sep 14;10(9):e0133599. doi: 10.1371/journal.pone.0133599. eCollection 2015. PMID: 26368541; PMCID: PMC4569346.
Copy Download .nbib Format: NLM
Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?.

Endoscopy international open

Ono S, Myojo M, Harada H, Tsuji K, Murakami D, Suehiro S, Doyama H, Ando J, Saito I, Fujishiro M, Komuro I, Koike K.
PMID: 28924604
Endosc Int Open. 2017 Sep;5(9):E943-E949. doi: 10.1055/s-0043-116381. Epub 2017 Sep 13.

BACKGROUND AND STUDY AIMS : Combined use of thienopyridine derivatives and other antithrombotic agents is reported to be a risk factor for postoperative bleeding after gastric endoscopic submucosal dissection (ESD). However, risk associated with a single thienopyridine derivative has...

Cite
Ono S, Myojo M, Harada H, et al. Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endosc Int Open. 2017;5(9):E943-E949doi: 10.1055/s-0043-116381.
Ono, S., Myojo, M., Harada, H., Tsuji, K., Murakami, D., Suehiro, S., Doyama, H., Ando, J., Saito, I., Fujishiro, M., Komuro, I., & Koike, K. (2017). Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endoscopy international open, 5(9), E943-E949. https://doi.org/10.1055/s-0043-116381
Ono, Satoshi, et al. "Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?." Endoscopy international open vol. 5,9 (2017): E943-E949. doi: https://doi.org/10.1055/s-0043-116381
Ono S, Myojo M, Harada H, Tsuji K, Murakami D, Suehiro S, Doyama H, Ando J, Saito I, Fujishiro M, Komuro I, Koike K. Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endosc Int Open. 2017 Sep;5(9):E943-E949. doi: 10.1055/s-0043-116381. Epub 2017 Sep 13. PMID: 28924604; PMCID: PMC5597936.
Copy Download .nbib Format: NLM
Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature.

Case reports in obstetrics and gynecology

Aoyama K, Matsushima H, Sawada M, Mori T, Yasukawa S, Kitawaki J.
PMID: 27668109
Case Rep Obstet Gynecol. 2016;2016:1712404. doi: 10.1155/2016/1712404. Epub 2016 Sep 07.

Primary vulvar adenocarcinomas are very rare. We describe the rare case of primary vulvar apocrine adenocarcinoma, a histologically rare subtype of vulvar adenocarcinoma. A 57-year-old Japanese woman presented with an enlarging vulvar mass. A dark-red, hemorrhagic, ulcerated tumor was...

Cite
Aoyama K, Matsushima H, Sawada M, et al. Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature. Case Rep Obstet Gynecol. 2016;2016:1712404doi: 10.1155/2016/1712404.
Aoyama, K., Matsushima, H., Sawada, M., Mori, T., Yasukawa, S., & Kitawaki, J. (2016). Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature. Case reports in obstetrics and gynecology, 20161712404. https://doi.org/10.1155/2016/1712404
Aoyama, Kohei, et al. "Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature." Case reports in obstetrics and gynecology vol. 2016 (2016): 1712404. doi: https://doi.org/10.1155/2016/1712404
Aoyama K, Matsushima H, Sawada M, Mori T, Yasukawa S, Kitawaki J. Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature. Case Rep Obstet Gynecol. 2016;2016:1712404. doi: 10.1155/2016/1712404. Epub 2016 Sep 07. PMID: 27668109; PMCID: PMC5030426.
Copy Download .nbib Format: NLM
Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

Annals of surgical oncology

Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.
PMID: 26170193
Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8.

No abstract available.

Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy Download .nbib Format: NLM
Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis.

Journal of cell communication and signaling

El-Seoudi A, Abd El Kader T, Nishida T, Eguchi T, Aoyama E, Takigawa M, Kubota S.
PMID: 28343287
J Cell Commun Signal. 2017 Sep;11(3):255-263. doi: 10.1007/s12079-017-0384-8. Epub 2017 Mar 25.

Fibroblast growth factor 1 (FGF-1) is a classical member of the FGF family and is produced by chondrocytes cultured from osteoarthritic patients. Also, this growth factor was shown to bind to CCN family protein 2 (CCN2), which regenerates damaged...

Cite
El-Seoudi A, Abd El Kader T, Nishida T, et al. Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis. J Cell Commun Signal. 2017;11(3):255-263doi: 10.1007/s12079-017-0384-8.
El-Seoudi, A., Abd El Kader, T., Nishida, T., Eguchi, T., Aoyama, E., Takigawa, M., & Kubota, S. (2017). Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis. Journal of cell communication and signaling, 11(3), 255-263. https://doi.org/10.1007/s12079-017-0384-8
El-Seoudi, Abdellatif, et al. "Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis." Journal of cell communication and signaling vol. 11,3 (2017): 255-263. doi: https://doi.org/10.1007/s12079-017-0384-8
El-Seoudi A, Abd El Kader T, Nishida T, Eguchi T, Aoyama E, Takigawa M, Kubota S. Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis. J Cell Commun Signal. 2017 Sep;11(3):255-263. doi: 10.1007/s12079-017-0384-8. Epub 2017 Mar 25. PMID: 28343287; PMCID: PMC5559396.
Copy Download .nbib Format: NLM
Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.

Oncology letters

Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N, Yamamoto N, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Imada T, Masuda M.
PMID: 28356977
Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14.

Overall survival remains unsatisfactory in stage II/III gastric cancer, even after curative surgery and adjuvant chemotherapy. Platelet-derived growth factor receptor-β (

Cite
Higuchi A, Oshima T, Yoshihara K, et al. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2016;13(2):905-911doi: 10.3892/ol.2016.5494.
Higuchi, A., Oshima, T., Yoshihara, K., Sakamaki, K., Aoyama, T., Suganuma, N., Yamamoto, N., Sato, T., Cho, H., Shiozawa, M., Yoshikawa, T., Rino, Y., Kunisaki, C., Imada, T., & Masuda, M. (2017). Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncology letters, 13(2), 905-911. https://doi.org/10.3892/ol.2016.5494
Higuchi, Akio, et al. "Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy." Oncology letters vol. 13,2 (2017): 905-911. doi: https://doi.org/10.3892/ol.2016.5494
Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N, Yamamoto N, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Imada T, Masuda M. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14. PMID: 28356977; PMCID: PMC5351282.
Copy Download .nbib Format: NLM
Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline.

Bioscience, biotechnology, and biochemistry

Aoyama Y, Ishikawa T, Amano N, Yoshida A.
PMID: 27280666
Biosci Biotechnol Biochem. 1992 Jan;56(4):656-9. doi: 10.1271/bbb.56.656.

The effects on liver and serum lipids of rats of excess cystine added to their casein or soy protein isolate diets were studied. When excess cystine was added to the casein diet, liver lipids were not changed. Using soy...

Cite
Aoyama Y, Ishikawa T, Amano N, et al. Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline. Biosci Biotechnol Biochem. 1992;56(4):656-9doi: 10.1271/bbb.56.656.
Aoyama, Y., Ishikawa, T., Amano, N., & Yoshida, A. (1992). Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline. Bioscience, biotechnology, and biochemistry, 56(4), 656-9. https://doi.org/10.1271/bbb.56.656
Aoyama, Y, et al. "Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline." Bioscience, biotechnology, and biochemistry vol. 56,4 (1992): 656-9. doi: https://doi.org/10.1271/bbb.56.656
Aoyama Y, Ishikawa T, Amano N, Yoshida A. Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline. Biosci Biotechnol Biochem. 1992 Jan;56(4):656-9. doi: 10.1271/bbb.56.656. PMID: 27280666.
Copy Download .nbib Format: NLM
Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty.

Physical therapy research

Nankaku M, Tsuboyama T, Aoyama T, Kuroda Y, Ikeguchi R, Matsuda S.
PMID: 28289576
Phys Ther Res. 2016 Jul 14;19(1):8-12. doi: 10.1298/ptr.e9884. eCollection 2016.

PURPOSE: To elucidate the relation between certain preoperative physical parameters and walking with a limp after total hip arthroplasty (THA) and determine whether it is possible to predict the walking ability of patients 6 months after THA.METHODS: The subjects...

Cite
Nankaku M, Tsuboyama T, Aoyama T, et al. Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Phys Ther Res. 2016;19(1):8-12doi: 10.1298/ptr.e9884.
Nankaku, M., Tsuboyama, T., Aoyama, T., Kuroda, Y., Ikeguchi, R., & Matsuda, S. (2016). Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Physical therapy research, 19(1), 8-12. https://doi.org/10.1298/ptr.e9884
Nankaku, Manabu, et al. "Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty." Physical therapy research vol. 19,1 (2016): 8-12. doi: https://doi.org/10.1298/ptr.e9884
Nankaku M, Tsuboyama T, Aoyama T, Kuroda Y, Ikeguchi R, Matsuda S. Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Phys Ther Res. 2016 Jul 14;19(1):8-12. doi: 10.1298/ptr.e9884. eCollection 2016. PMID: 28289576; PMCID: PMC5342965.
Copy Download .nbib Format: NLM
Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S.
PMID: 29473277
Hepatol Res. 2018 Aug;48(9):757-767. doi: 10.1111/hepr.13071. Epub 2018 Apr 10.

AIM: Hepatic inclusion composed of autophagy-specific substrate p62 is one of the histological features of non-alcoholic fatty liver disease (NAFLD) and can be a precursor to hepatic carcinogenesis. The expression of p62 was enhanced by not only autophagic dysfunction...

Cite
Fukushima H, Yamashina S, Arakawa A, et al. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res. 2018;48(9):757-767doi: 10.1111/hepr.13071.
Fukushima, H., Yamashina, S., Arakawa, A., Taniguchi, G., Aoyama, T., Uchiyama, A., Kon, K., Ikejima, K., & Watanabe, S. (2018). Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology, 48(9), 757-767. https://doi.org/10.1111/hepr.13071
Fukushima, Hirofumi, et al. "Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,9 (2018): 757-767. doi: https://doi.org/10.1111/hepr.13071
Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res. 2018 Aug;48(9):757-767. doi: 10.1111/hepr.13071. Epub 2018 Apr 10. PMID: 29473277.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 978 entries